George Ng - Jan 27, 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director
Signature
/s/ George Ng, by Neda A. Sharifi, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jan 27, 2025
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/18/2025, 05:53 PM
Date Of Original Report
Jan 29, 2025
Previous filing
Jan 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 87.2K Jan 27, 2025 George Ng IRRA FBO: George Ng
holding PCSA Common Stock 20K Jan 27, 2025 Ng Cha Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +87.2K $0.00 87.2K Jan 29, 2025 Common Stock 87.2K $0.65 George Ng IRRA FBO: George Ng
transaction PCSA Warrants Award $0 +43.6K $0.00 43.6K Jan 29, 2025 Common Stock 43.6K $0.65 George Ng IRRA FBO: George Ng
* An asterisk sign (*) next to the price indicates that the price is likely invalid.